Dose-modified lenalidomide induces sustained hematological response in patients with intermediate to high risk myelodysplasia

Detalles Bibliográficos
Autores principales: Khalafallah, Alhossain, Brain, Terry
Formato: Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2010
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033134/
https://www.ncbi.nlm.nih.gov/pubmed/21415965
http://dx.doi.org/10.4084/MJHID.2010.012
_version_ 1782197545303277568
author Khalafallah, Alhossain
Brain, Terry
author_facet Khalafallah, Alhossain
Brain, Terry
author_sort Khalafallah, Alhossain
collection PubMed
description
format Text
id pubmed-3033134
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Università Cattolica del Sacro Cuore
record_format MEDLINE/PubMed
spelling pubmed-30331342011-03-17 Dose-modified lenalidomide induces sustained hematological response in patients with intermediate to high risk myelodysplasia Khalafallah, Alhossain Brain, Terry Mediterr J Hematol Infect Dis Letter to the Editor Università Cattolica del Sacro Cuore 2010-05-31 /pmc/articles/PMC3033134/ /pubmed/21415965 http://dx.doi.org/10.4084/MJHID.2010.012 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
spellingShingle Letter to the Editor
Khalafallah, Alhossain
Brain, Terry
Dose-modified lenalidomide induces sustained hematological response in patients with intermediate to high risk myelodysplasia
title Dose-modified lenalidomide induces sustained hematological response in patients with intermediate to high risk myelodysplasia
title_full Dose-modified lenalidomide induces sustained hematological response in patients with intermediate to high risk myelodysplasia
title_fullStr Dose-modified lenalidomide induces sustained hematological response in patients with intermediate to high risk myelodysplasia
title_full_unstemmed Dose-modified lenalidomide induces sustained hematological response in patients with intermediate to high risk myelodysplasia
title_short Dose-modified lenalidomide induces sustained hematological response in patients with intermediate to high risk myelodysplasia
title_sort dose-modified lenalidomide induces sustained hematological response in patients with intermediate to high risk myelodysplasia
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033134/
https://www.ncbi.nlm.nih.gov/pubmed/21415965
http://dx.doi.org/10.4084/MJHID.2010.012
work_keys_str_mv AT khalafallahalhossain dosemodifiedlenalidomideinducessustainedhematologicalresponseinpatientswithintermediatetohighriskmyelodysplasia
AT brainterry dosemodifiedlenalidomideinducessustainedhematologicalresponseinpatientswithintermediatetohighriskmyelodysplasia

Ejemplares similares